Mentice AB Stock: price and insider trades · Sweden

Mentice AB, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to Finansinspektionen. 3 insiders have disclosed 3 filings since 18 October 2025.

No insider sold shares on the market over the period. Instead, the filings list 3 purchases totalling €5.6M, made by 3 insiders. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The buyers include 2 board members and 1 chief executive. The largest single trade was a purchase of €5.5M by Lawrence Howell, published on 12 December 2025, equal to 15.9% of the market capitalisation.

For context, the typical company on the same exchange (median of 885 companies) published 7 filings over the same period, against 3 filings here. Since 2025, the database holds 5 purchases and no sales by insiders of the company.

In the case of 1 purchase, another manager of the company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. The most recent open-market purchase was published on 18 June 2026, 121 days ago. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for notifying a trade is three business days (MAR article 19).

For comparison within the same sector, see the insider buying recorded at MAIA Biotechnology, Inc. and Cooper Companies, Inc. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.